Syndax Pharmaceuticals Inc (SNDX)
16.09
+0.49
(+3.14%)
USD |
NASDAQ |
Nov 22, 16:00
16.09
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Price to Book Value: 3.748 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 3.748 |
| November 21, 2024 | 3.634 |
| November 20, 2024 | 3.715 |
| November 19, 2024 | 3.674 |
| November 18, 2024 | 3.753 |
| November 15, 2024 | 3.688 |
| November 14, 2024 | 3.911 |
| November 13, 2024 | 3.874 |
| November 12, 2024 | 3.776 |
| November 11, 2024 | 5.074 |
| November 08, 2024 | 5.080 |
| November 07, 2024 | 5.013 |
| November 06, 2024 | 4.973 |
| November 05, 2024 | 4.587 |
| November 04, 2024 | 4.412 |
| November 01, 2024 | 4.421 |
| October 31, 2024 | 4.390 |
| October 30, 2024 | 4.404 |
| October 29, 2024 | 4.441 |
| October 28, 2024 | 4.471 |
| October 25, 2024 | 4.364 |
| October 24, 2024 | 4.420 |
| October 23, 2024 | 4.315 |
| October 22, 2024 | 4.459 |
| October 21, 2024 | 4.546 |
| Date | Value |
|---|---|
| October 18, 2024 | 4.587 |
| October 17, 2024 | 4.629 |
| October 16, 2024 | 4.629 |
| October 15, 2024 | 4.597 |
| October 14, 2024 | 4.613 |
| October 11, 2024 | 4.452 |
| October 10, 2024 | 4.236 |
| October 09, 2024 | 4.264 |
| October 08, 2024 | 4.278 |
| October 07, 2024 | 4.250 |
| October 04, 2024 | 4.380 |
| October 03, 2024 | 4.35 |
| October 02, 2024 | 4.525 |
| October 01, 2024 | 4.629 |
| September 30, 2024 | 4.480 |
| September 27, 2024 | 3.701 |
| September 26, 2024 | 3.558 |
| September 25, 2024 | 3.530 |
| September 24, 2024 | 3.582 |
| September 23, 2024 | 3.513 |
| September 20, 2024 | 3.580 |
| September 19, 2024 | 3.65 |
| September 18, 2024 | 3.527 |
| September 17, 2024 | 3.538 |
| September 16, 2024 | 3.566 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.998
Minimum
Feb 14 2022
14.15
Maximum
May 15 2020
4.355
Average
3.818
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 7.43 |
| Moderna Inc | 1.326 |
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.360 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1089 |
| Price | 16.09 |
| Earnings Yield | -22.56% |
| Market Cap | 1.373B |
| PEGY Ratio | -0.1089 |